Science University Research Symposium (SURS)
Breaking the Cycle: Targeting Mitochondrial Dysfunction in Pompe Disease
Publication Date
Fall 2026
College
College of Sciences & Mathematics
Department
Biology, Department of
SURS Faculty Advisor
Felicity Sterling
Presentation Type
Poster Presentation
Abstract
Pompe disease is a rare genetic disorder caused by mutations in the acid alpha-glucosidase (GAA) gene, resulting in the abnormal accumulation of glycogen within lysosomes. This buildup can lead to cellular dysfunction, muscle damage, and nerve deterioration. Because current treatments have limitations, identifying shared pathways between lysosomal storage disorders may provide insight into potential therapeutic targets. Recent studies on Niemann-Pick Type C (NPC) disease have demonstrated that overactive mTORC1 signaling can impair mitophagy, the process responsible for removing damaged mitochondria, and contribute to apoptosis. Our research focuses on exploring potential similarities between NPC and Pompe disease, specifically examining the relationship between mTORC1 signaling, mitochondrial health, and autophagy. We hypothesize that alterations in mTORC1 signaling may contribute to impaired mitochondrial function and autophagic activity in Pompe disease. COS-7 cells were used to observe mitochondrial fragmentation and autophagy through LC3 immunofluorescence. Understanding how these cellular pathways contribute to Pompe disease may help identify shared mechanisms among lysosomal storage disorders and provide direction for future therapeutic research.
Recommended Citation
Reagan, Ashlyn and Gordy, Charlotte, "Breaking the Cycle: Targeting Mitochondrial Dysfunction in Pompe Disease" (2026). Science University Research Symposium (SURS). 429.
https://repository.belmont.edu/surs/429
